Hendrik Pels

2.4k total citations
48 papers, 1.6k citations indexed

About

Hendrik Pels is a scholar working on Neurology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Hendrik Pels has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Neurology, 31 papers in Genetics and 22 papers in Pathology and Forensic Medicine. Recurrent topics in Hendrik Pels's work include CNS Lymphoma Diagnosis and Treatment (35 papers), Glioma Diagnosis and Treatment (29 papers) and Lymphoma Diagnosis and Treatment (22 papers). Hendrik Pels is often cited by papers focused on CNS Lymphoma Diagnosis and Treatment (35 papers), Glioma Diagnosis and Treatment (29 papers) and Lymphoma Diagnosis and Treatment (22 papers). Hendrik Pels collaborates with scholars based in Germany, United States and Switzerland. Hendrik Pels's co-authors include Uwe Schlegel, Ingo G.H. Schmidt‐Wolf, Thomas Klockgether, Axel Glasmacher, H. Schulz, Michael Linnebank, Martina Deckert, Andreas Engert, Horst Urbach and U. Bode and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hendrik Pels

48 papers receiving 1.5k citations

Peers

Hendrik Pels

NEURO

GENET

PFM

PRM

ONCOL

Ira M. Garonzik United States

Michael Powell United Kingdom

Achille Stevenaert Belgium

F. Lapierre France

B Guidetti Italy

Eduardo Fernández Italy

Selçuk Peker Türkiye

Brien G. Benoit Canada

Stéphane Derrey France

Chun‐Po Yen United States

Ira M. Garonzik United States

Hendrik Pels

537 ×0.5

NEURO

430 ×0.5

GENET

286 ×0.3

PFM

295 ×0.9

PRM

62 ×0.5

ONCOL

Citations per year, relative to Hendrik Pels Hendrik Pels (= 1×) peers Ira M. Garonzik

Countries citing papers authored by Hendrik Pels

Since Specialization

Citations

This map shows the geographic impact of Hendrik Pels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Pels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Pels more than expected).

Fields of papers citing papers by Hendrik Pels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hendrik Pels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Pels. The network helps show where Hendrik Pels may publish in the future.

Co-authorship network of co-authors of Hendrik Pels

This figure shows the co-authorship network connecting the top 25 collaborators of Hendrik Pels. A scholar is included among the top collaborators of Hendrik Pels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hendrik Pels. Hendrik Pels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keßler, Almuth F., Peter Hau, Elisabeth Bumes, et al.. (2022). The Emesis Trial: Depressive Glioma Patients Are More Affected by Chemotherapy-Induced Nausea and Vomiting. Frontiers in Neurology. 13. 773265–773265. 5 indexed citations

Seidel, Sabine, Agnieszka Korfel, Thomas E. Kowalski, et al.. (2019). HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis. SHILAP Revista de lepidopterología. 1(1). 17–17. 12 indexed citations

Schlachetzki, Felix, Moriz Herzberg, Thilo Hölscher, et al.. (2012). Transcranial Ultrasound from Diagnosis to Early Stroke Treatment – Part 2: Prehospital Neurosonography in Patients with Acute Stroke – The Regensburg Stroke Mobile Project. Cerebrovascular Diseases. 33(3). 262–271. 58 indexed citations

Schulte‐Altedorneburg, Gernot, L. Heuser, & Hendrik Pels. (2011). MRI patterns in recurrence of primary CNS lymphoma in immunocompetent patients. European Journal of Radiology. 81(9). 2380–2385. 14 indexed citations

Pels, Hendrik, et al.. (2010). Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma. Journal of Neuro-Oncology. 103(3). 635–640. 25 indexed citations

Schroers, Roland, Alexander Baraniskin, Matthias Vorgerd, et al.. (2010). Diagnosis of leptomeningeal disease in diffuse large B‐cell lymphomas of the central nervous system by flow cytometry and cytopathology. European Journal Of Haematology. 85(6). 520–528. 60 indexed citations

Pels, Hendrik, Klaus Fließbach, Axel Glasmacher, et al.. (2009). Long‐term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Annals of Neurology. 67(2). 182–189. 82 indexed citations

Linnebank, Michael, Susanna Moskau, Matthias Simon, et al.. (2008). Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma. Neuro-Oncology. 11(1). 2–8. 41 indexed citations

Becker, Albert J., Sandra Vezmar, Michael Linnebank, et al.. (2007). Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate. International Journal of Clinical Pharmacology and Therapeutics. 45(9). 504–515. 23 indexed citations

10.

Linnebank, Michael, et al.. (2007). Acute Methotrexate-Induced Encephalopathy - Causal Relation to Homozygous Allelic State for MTR c.2756A>G (D919G)?. Journal of Chemotherapy. 19(4). 455–457. 13 indexed citations

11.

Pels, Hendrik & Uwe Schlegel. (2006). Primary central nervous system lymphoma. Current Treatment Options in Neurology. 8(4). 346–357. 13 indexed citations

12.

Jahnke, Kristoph, Agnieszka Korfel, Brian Patrick O’Neill, et al.. (2006). International study on low‐grade primary central nervous system lymphoma. Annals of Neurology. 59(5). 755–762. 44 indexed citations

13.

Linnebank, Michael, Stephan Schmidt, Heike Kölsch, et al.. (2004). The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. British Journal of Cancer. 90(10). 1969–1971. 33 indexed citations

14.

Schmidt‐Wolf, Ingo G.H., Jürgen K. Rockstroh, Uwe Schlegel, et al.. (2003). Treatment options of AIDS-related lymphoma. Expert Opinion on Pharmacotherapy. 4(8). 1331–1343. 2 indexed citations

15.

Pels, Hendrik, et al.. (2002). Intraventricular and Intravenous Treatment of a Patient with Refractory Primary CNS Lymphoma using Rituximab. Journal of Neuro-Oncology. 59(3). 213–216. 54 indexed citations

16.

Glasmacher, Axel, Hendrik Pels, Christoph Helmstaedter, et al.. (2001). Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: Superior results in patients younger than 60 years. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

17.

Cornely, Oliver A., et al.. (2001). A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation. Bone Marrow Transplantation. 28(9). 899–901. 1 indexed citations

18.

Pels, Hendrik, Ina R. Vogt, Thomas Klockgether, & Uwe Schlegel. (2000). Primary Non-Hodgkin’s Lymphoma of the Spinal Cord. Spine. 25(17). 2262–2264. 20 indexed citations

19.

Urbach, Horst, et al.. (2000). Primary central nervous system immunocytoma: MRI and spectroscopy. Neuroradiology. 42(10). 738–741. 17 indexed citations

20.

Schlegel, Uwe, et al.. (1999). Neurologic Sequelae of Treatment of Primary CNS Lymphomas. Journal of Neuro-Oncology. 43(3). 277–286. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact